Vertex Pharmaceuticals Inc. (VRTX): Price and Financial Metrics

VRTX POWR Grades

• VRTX scores best on the Quality dimension, with a Quality rank ahead of 97.49% of US stocks.
• The strongest trend for VRTX is in Growth, which has been heading down over the past 177 days.
• VRTX ranks lowest in Momentum; there it ranks in the 35th percentile.

VRTX Stock Summary

• VERTEX PHARMACEUTICALS INC's market capitalization of $77,977,729,289 is ahead of 97.23% of US-listed equities.
• Of note is the ratio of VERTEX PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; just 11.64% of US stocks have a lower such ratio.
• The volatility of VERTEX PHARMACEUTICALS INC's share price is greater than that of just 12.76% US stocks with at least 200 days of trading history.
• Stocks that are quantitatively similar to VRTX, based on their financial statements, market capitalization, and price volatility, are MU, LRCX, REGN, AMAT, and INTC.
• VRTX's SEC filings can be seen here. And to visit VERTEX PHARMACEUTICALS INC's official web site, go to www.vrtx.com.

VRTX Valuation Summary

• In comparison to the median Healthcare stock, VRTX's price/sales ratio is 347.62% higher, now standing at 9.4.
• Over the past 243 months, VRTX's EV/EBIT ratio has gone up 38.2.

Below are key valuation metrics over time for VRTX.

VRTX Growth Metrics

The 5 year cash and equivalents growth rate now stands at 242.8%.
• Its 4 year net cashflow from operations growth rate is now at 298.55%.
• The 3 year revenue growth rate now stands at 143.4%.

VRTX's revenue has moved up $5,871,436,000 over the prior 49 months.

The table below shows VRTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	8,700.561	4,046.493	3,273.21
2022-06-30	8,350.425	4,018.212	3,194.638
2022-03-31	7,947.595	2,678.645	2,451.062
2021-12-31	7,574.4	2,643.5	2,342.1
2021-09-30	7,129.659	2,140.039	2,176.18
2021-06-30	6,683.766	2,120.568	1,991.686

VRTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VRTX has a Quality Grade of B, ranking ahead of 86.88% of graded US stocks.
• VRTX's asset turnover comes in at 0.564 -- ranking 66th of 681 Pharmaceutical Products stocks.
• ORGO, MDWD, and CCXI are the stocks whose asset turnover ratios are most correlated with VRTX.

The table below shows VRTX's key quality metrics over time.